Asensus Surgical Financials

Asensus Surgical Stock Summary

Asensus Surgical competes with Spectrum Brands, United Guardian, Procter Gamble, NETGEAR, and Inter Parfums. Asensus Surgical, Inc. engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. Asensus Surgical, Inc. was founded in 2006 and is based in Morrisville, North Carolina. Transenterix operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 160 people.

Asensus Surgical Key Financial Ratios

Generally speaking, Asensus Surgical's financial ratios allow both analysts and investors to convert raw data from Asensus Surgical's financial statements into concise, actionable information that can be used to evaluate the performance of Asensus Surgical over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Asensus Surgical reports annually and quarterly.

Asensus Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Asensus Surgical's current stock value. Our valuation model uses many indicators to compare Asensus Surgical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Asensus Surgical competition to find correlations between indicators driving Asensus Surgical's intrinsic value. More Info.Asensus Surgical is currently regarded as top stock in return on equity category among related companies. It is currently regarded as top stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Asensus Surgical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Asensus Surgical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Asensus Surgical's earnings, one of the primary drivers of an investment's value.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

If you are still planning to invest in Asensus Surgical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Asensus Surgical's history and understand the potential risks before investing.